Correlation Between Nasdaq and Ono Pharmaceutical
Can any of the company-specific risk be diversified away by investing in both Nasdaq and Ono Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nasdaq and Ono Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nasdaq Inc and Ono Pharmaceutical Co, you can compare the effects of market volatilities on Nasdaq and Ono Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nasdaq with a short position of Ono Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nasdaq and Ono Pharmaceutical.
Diversification Opportunities for Nasdaq and Ono Pharmaceutical
-0.09 | Correlation Coefficient |
Good diversification
The 3 months correlation between Nasdaq and Ono is -0.09. Overlapping area represents the amount of risk that can be diversified away by holding Nasdaq Inc and Ono Pharmaceutical Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ono Pharmaceutical and Nasdaq is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nasdaq Inc are associated (or correlated) with Ono Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ono Pharmaceutical has no effect on the direction of Nasdaq i.e., Nasdaq and Ono Pharmaceutical go up and down completely randomly.
Pair Corralation between Nasdaq and Ono Pharmaceutical
Given the investment horizon of 90 days Nasdaq Inc is expected to under-perform the Ono Pharmaceutical. But the stock apears to be less risky and, when comparing its historical volatility, Nasdaq Inc is 3.81 times less risky than Ono Pharmaceutical. The stock trades about 0.0 of its potential returns per unit of risk. The Ono Pharmaceutical Co is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 1,084 in Ono Pharmaceutical Co on December 27, 2024 and sell it today you would earn a total of 35.00 from holding Ono Pharmaceutical Co or generate 3.23% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 41.67% |
Values | Daily Returns |
Nasdaq Inc vs. Ono Pharmaceutical Co
Performance |
Timeline |
Nasdaq Inc |
Ono Pharmaceutical |
Risk-Adjusted Performance
Insignificant
Weak | Strong |
Nasdaq and Ono Pharmaceutical Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Nasdaq and Ono Pharmaceutical
The main advantage of trading using opposite Nasdaq and Ono Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nasdaq position performs unexpectedly, Ono Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ono Pharmaceutical will offset losses from the drop in Ono Pharmaceutical's long position.The idea behind Nasdaq Inc and Ono Pharmaceutical Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.Ono Pharmaceutical vs. Sanofi ADR | Ono Pharmaceutical vs. Bristol Myers Squibb | Ono Pharmaceutical vs. AstraZeneca PLC ADR | Ono Pharmaceutical vs. Gilead Sciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |